International Congress Munich 2014


MS06 What's new in pneumococcal vaccination?

Morning Seminar
Chairs: D. Stolz (Basel, Switzerland)
Aims: To discuss the impact of pneumococcal diseases, both invasive and noninvasive, in Europe and to review the current evidence regarding polysaccharide and conjugate vaccines.

HERMES SYLLABUS LINKS
ADULT: Module E.1.20 Treatment modalities and prevention measures, Vaccination and infection control, Module B.3.3 Non-TB respiratory infections, Community-acquired pneumonia

Educational Material

Handout MS6
Open
How to access educational materials from mobile devices
Why do we need to vaccinate against pneumonia?
G. Rohde (Maastricht, The Netherlands)
PDF journal article, handout or slides
PDF journal article, handout or slides
Pneumococcal vaccine: when, what, how and to whom
F. Blasi (Milan, Italy)
Slide presentationPDF journal article, handout or slides
Slide presentationPDF journal article, handout or slides